Approved Hospital Formulary
QR Code Add Formweb to your mobile device

Formulary synchronization in progress.
Please refer to Epic and your local pharmacy for available medications.

Approved Hospital Formulary
Search results for:

glucarpidase

glucarpidase
  • Provider restrictions: Restricted to hematology/oncology providers
  • Patient restrictions: Restricts to patients with clinically toxic plasma methotrexate concentrations (>1 μM/L) and impaired renal function
  • Patient restrictions: Requires a review of use by the HM Oncology Exception Review Panel physician
  • Pharmacy Consult: Mandatory pharmacy consult to screen glucarpidase therapy
Brand names: Voraxaze
Form Strength
INJECTION, INTRAVENOUS 1,000 units

VIEW MORE antidotes
CLASS
m00106

 

Policies and procedures

 

Consults, protocols, and therapeutic interchanges

Requires a mandatory “Pharmacy consult to screen glucarpidase therapy”

 

Additional information

Each 1,000 unit vial costs $30,753. A 50 u/kg dose in a 70 kg patient costs $123,012.


Last updated: Aug. 24, 2022


This site is intended for the staff of Houston Methodist.
While others may view accessible pages, Houston Methodist makes no warranty, express or implied,
as to the use of this information outside of Houston Methodist.